Situation.
Listed manufacturer with approximately EUR 350m revenue and a defensible technology position in a growing clinical niche.
Corporate strategy.
Listed precision medical technology manufacturer
Challenge.
Growth depended on 12 candidate geographies and three adjacent applications with different commercial models and regulatory burdens. No ranked view existed.
What we did.
Prioritised markets and applications, assessed routes to market per geography and developed a growth plan with investment gates.
The outcome.
The shortlist was reduced from 12 markets to four, with a gated investment plan of approximately EUR 53m over three years and a revenue ambition of 15% p.a.
Anonymised engagement. Figures are approximate. Targets, assessed potential, approved programmes and realised results are described separately in the outcome. Converted amounts use ECB reference rates dated 18 September 2026, rounded to two significant figures.
More Strategic Decisions cases →Facing a similar challenge?
Contact Bearaco’s partners
Let's talk